Cargando…
SAT099 Should We Use HbA1c Or Continuous Glucose Monitoring (CGM) For Treatment Adjustment In Type 2 Diabetes Non-insulin Treated Patients?
Disclosure: T. Totomirova: None. M. Arnaudova: None. Current recommendations include treatment changes in type 2 non-insulin patients to be based preferably on HbA1c. HbA1c shows insufficiency as glucose control assessment tool omitting glucose fluctuations and hypoglycemic episodes. Continuous gluc...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553404/ http://dx.doi.org/10.1210/jendso/bvad114.965 |